ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > DLL3

DLL3

概要

Name:Delta-like protein 3
Target Synonym:Delta-Like Protein 3,Delta3,Delta-Like 3,Drosophila Delta Homolog 3,SCDO1,Delta-Like 3 (Drosophila),DLL3,Delta (Drosophila)-Like 3,Delta Like Canonical Notch Ligand 3
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:10
Lastest Research Phase:Phase 2 Clinical

製品リスト製品比較と製品注文

ACRO Quality

生物活性データの一部

DL3-HA2H3-Cell-based assay
 DLL3 CAR_T

5e5 of anti-DLL3 CAR-293 cells were stained with 100 μL of 1 μg/mL of Alexa Fluor 647-Labeled Human DLL3 Protein, His Tag (Cat. No. DL3-HA2H3) and negative control protein respectively (Fig. C and B), and non-transfected 293 cells were used as a control (Fig. A). Alexa 647 signal was used to evaluate the binding activity (QC tested).

DL3-C82E9-ELISA
 DLL3 ELISA

Immobilized Biotinylated Cynomolgus DLL3, His,Avitag (Cat. No. DL3-C82E9) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-DLL3 Antibody (specific Binding DSL of DLL3), Human IgG1 with a linear range of 0.1-1 ng/mL (QC tested).

DL3-H82E4-MALS-HPLC
DLL3 MALS images

The purity of Biotinylated Human DLL3, His,Avitag (Cat. No. DL3-H82E4) is more than 90% and the molecular weight of this protein is around 51-69 kDa verified by SEC-MALS.

Synonym Name

Delta3,delta-like 3 (Drosophila),delta-like protein 3,DLL3,Pudgy,SCDO1,SCDO1delta3

Background

Delta-like protein 3 (DLL3) is a transmembrane protein that belongs to the Delta/Serrate/Lag-2 (DSL) family of Notch ligands.May be required to divert neurons along a specific differentiation pathway. Plays a role in the formation of somite boundaries during segmentation of the paraxial mesoderm. DLL3 protein is expressed on the surface of tumor cells but not in normal adult tissues.

Clinical and Translational Updates

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
Rovalpituzumab tesirine SC-0002; SC0001SCX; SC16LD6.5; SC0001-SCX; P256HB60FF Phase 1 Clinical Stemcentrx Inc, Abbvie Inc Solid tumours; Small Cell Lung Carcinoma; Glioblastoma; Neoplasms; Prostatic Neoplasms; Medullary thyroid cancer (MTC); Carcinoma, Neuroendocrine; Melanoma Details
DLL3-CAR-NK cells Therapy(Tianjin Medical University Cancer Institute and Hospital) DLL3-CAR-NK cells Phase 1 Clinical Tianjin Medical University Cancer Institute And Hospital Small Cell Lung Carcinoma Details
OBT620 OBT620 Phase 1 Clinical Boehringer Ingelheim Gmbh, Oxford Biotherapeutics Ltd Small Cell Lung Carcinoma Details
89Zr-DFO-SC16.56 89Zr-DFO-SC16.56 Phase 1 Clinical Memorial Sloan Kettering Cancer Center Small Cell Lung Carcinoma Details
QLS-31904 QLS31904; QLS-31904 Phase 1 Clinical Qilu Pharmaceutical Co Ltd Solid tumours Details
HPN-328 HPN-328 Phase 2 Clinical Harpoon Therapeutics Small Cell Lung Carcinoma Details
BI-764532 BI-764532 Phase 1 Clinical C.H. Boehringer Sohn Ag & Co. Kg Small Cell Lung Carcinoma; Neoplasms Details
PT-217 PT-217 Phase 1 Clinical Phanes Therapeutics Inc Small Cell Lung Carcinoma; Pancreatic neuroendocrine tumors (pNET); Prostatic Neoplasms; Carcinoma, Neuroendocrine Details
Tarlatamab AMG-757 Phase 2 Clinical Amgen Inc Small Cell Lung Carcinoma; Prostatic Neoplasms Details
LB-2102(Legend Biotechnology) LB-2102 Phase 1 Clinical Nanjing Legend Biotechnology Co Ltd Small Cell Lung Carcinoma; Neuroendocrine Tumors Details

This web search service is supported by Google Inc.

totopphone